期刊文献+

MEK-8222k血细胞分析仪性能验证及评价 被引量:4

下载PDF
导出
摘要 目的评价MEK-8222k血细胞分析仪的主要性能。方法通过本底检测、准确度、精密度、携带污染率、线性范围及WBC分类的重复性、正确度、异常标本的报警等试验对MEK-8222k血细胞分析仪性能进行验证。结果 MEK-8222k血细胞分析仪的本底值低,WBC、RBC、Hb、HCT、PLT的批内、批间精密度均在允许范围以内,携带污染率低,准确度高,线性范围良好,WBC分类与显微镜分类的相关性随细胞种类有差异。结论 MEK-8222k全自动血细胞分析仪各方面性能良好,符合实验室血细胞分析仪的性能要求,适用于临床血细胞分析的检验。
出处 《国际检验医学杂志》 CAS 2016年第3期397-399,共3页 International Journal of Laboratory Medicine
  • 相关文献

参考文献8

  • 1中国合格评定国家认可委员会.IS0151892012医学实验室质量和能力认可准则[S].北京:中国合格评定国家认可委员会,2012.
  • 2中华人民共和国卫生部.WS/T 406-2012临床血液学检验常规项目分析质量要求[S].2012.
  • 3National Committee for Clinical Laboratory Standards. EP15-A User demonstration of performance for precision and accuracy[S]. Wayne,PA,USA:NCCLS,2001:1-15.
  • 4National Committee for Clinical Laboratory Standards. EP6 A E valuation of the linearity of quantitative measurement proeedures: a statistical approach[S]. Wayne, PA, USA :NCCLS, 2003 :1-47.
  • 5National Committee for Clinical Laboratory Standards. EP10-A2 Pre- liminary evaluation of quantitative clinical laboratory methods, ap- proved guideline[S]. 2nd ed. Wayne, PA, USA: NCCLS, 2002 : 1-47.
  • 6张莉,吴炯,郭玮,潘柏申.医学检验检测系统应用前的性能评价[J].检验医学,2006,21(6):560-563. 被引量:71
  • 7杨有业,张秀明.临床检验方法学评价[M].北京:人民卫生出版社,2008:118-127.
  • 8Department of Health and Human Services,Centers for Medicare Medicaid Services. Medicare, medicaid and CLIA programs; reg- ulations implementing the clinical laboratory imProvement amend- ments of 1988 (CLIA)-HCFA. Final .rule with comment period [J[. Federal Register, !992,57(40) : 105-107.

二级参考文献14

  • 1U.S. Department of Health and Human Services. 42 CFR Part 493: medicare, medicaid and CLIA programs;Laboratory requirements relating to quality systems and certain personnel qualifications; Final rule[ J ]. Federal Register, 2003,68:3640-3714.
  • 2Jan SK. Evaluation of assay systems [ J ]. Clin Lab News,2001,27 : 10-14.
  • 3Laessig RH, Ehrmeyer SS, Leinweber JE. Intralaboratory performance requirements necessary to pass proficiency testing: CAP-1990 vs CLIA-1967 ( March 14,1990) formats compared [ J ]. Clin Chem, 1992,38 :895-903.
  • 4U.S. Department of Health and Human Services.Medical devices;Current good manufacturing practice(CGMP) final rule :quality system regulation. 21 CFRParts 808,812 and 820 [ J ]. Federal Register, 1996,61 : 52602-52662.
  • 5National Committee for Clinical Laboratory Standards.Evaluation of precision performance of clinical chemistry devices, approved guideline [ S ]. Wayne, PA:EPSoA. NCCLS. 1999.
  • 6U.S. Department of Health and Human Services.Medicare,medicaid and CLIA programs; Regulationsimplementing the clinical laboratory improvement amendments of 1998 (CLIA). Final rule [ J ]. Fed Regist, 1992,57:7002-7186.
  • 7VITROS system verification [ S ]. Ortho-Clinical Diagnotics, USA ,2004.
  • 8National Committee for Clinical Laboratory Standards.User demonstration of performance for precision and accuracy [ S ]. Wayne, PA : EP15-P. NCCLS. 1998.
  • 9National Committee for Clinical Laboratory Standards.Method comparison and bias estimation using patientsamples, approved guideline [ S ].2nd ed. Wayne, PA :EP9-A2. NCCLS. 2002.
  • 10National Committee for Clinical Laboratory Standards.Evaluation of the linearity of quantitative measurement procedures : a statistical approach, approved guideline[S]. Wayne,PA:EP6-A. NCCLS. 2003.

共引文献238

同被引文献25

引证文献4

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部